# Pharmacokinetics Study in Patients With Impaired Renal Function and Subjects With Normal Renal Function

> **NCT02603497** · PHASE1 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 31 (actual)

## Conditions studied

- Patients With Impaired Renal Function

## Interventions

- **DRUG:** ASP015K

## Key facts

- **NCT ID:** NCT02603497
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-24
- **Primary completion:** 2016-12-19
- **Final completion:** 2016-12-19
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2024-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02603497

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02603497, "Pharmacokinetics Study in Patients With Impaired Renal Function and Subjects With Normal Renal Function". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02603497. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*